Chartsbank is a comprehensive database containing information on more than 3000 new drugs in development, inclusive of pre-clinical research up to phase IV development

Subscribers view details.


 
Please Select Filter Criteria for the drug pipeline
Drug Pipeline by drug name:
Drug Pipeline by Company:
Drug Pipeline by Disease:

Subscribe

Drug Pipeline by Generic :
Drug Pipeline by Current Status:
Drug Pipeline by ICN:

...11121314151617181920...
CompanyDrug NameStatusIndication Group
OSI Tarceva Approved in USA, EU and SwitzerlandAntineoplastic & immunomodulating agents
Roche Tarceva Approved in USA and EUAntineoplastic & immunomodulating agents
Roche Tarceva Approved in EUAntineoplastic & immunomodulating agents
Roche Tarceva Submitted for approval in EUAntineoplastic & immunomodulating agents
ASCEND Therapeutics TamoGel accomplished Phase IIAntineoplastic & immunomodulating agents
Roche Tamiflu Approved in EU, submitted for approval in USAAnti-infectives for systemic use
Hana Biosciences Talvesta in Phase IIAntineoplastic & immunomodulating agents
Hana Biosciences Talvesta in Phase IIAntineoplastic & immunomodulating agents
Agennix Talactoferrin Alfa accomplished Phase IIDermatologicals
Agennix Talactoferrin Alfa accomplished Phase IIAntineoplastic & immunomodulating agents
Agennix Talactoferrin Alfa in Phase IIRespiratory system
ZymoGenetics TACI-Ig Phase II/III initiatedAntineoplastic & immunomodulating agents
ZymoGenetics TACI-Ig in Phase IIMusculoskeletal system
ZymoGenetics TACI-Ig accomplished Phase IAntineoplastic & immunomodulating agents
Amylin Symlin Approved in USAAlimentary tract & metabolism
Lilly Symbyax Approved in USANervous system
AstraZeneca SYMBICORT® Submittes in USARespiratory system
AstraZeneca Symbicort Single inhaler Therapy Approved in USA, submitted for approval in EURespiratory system
Xanthus Symadex in Phase IIAntineoplastic & immunomodulating agents
Pfizer Sutent Approved in USAAntineoplastic & immunomodulating agents
...11121314151617181920...




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.